To determine the association of anti-DFS70 antibodies with pathological activity status of LN patients, we divided LN patients into two groups based on whether they were positive or negative for anti-DFS70 antibodies, and then compared the differences of AI and CI between the groups. This evidence concerns the gene PSIP1 and lobular neoplasia.